| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.65B | +19.3% |
| Cost of Revenue | $750.4M | +8.9% |
| R&D Expense | $1.24B | +16.1% |
| SG&A Expense | $463.7M | -9.5% |
| Operating Income | $179.8M | +243.1% |
| Pre-tax Income | $287.6M | +1849.4% |
| Income Tax | -$1.57B | -8313.4% |
| Net Income | $1.86B | +5329.2% |
| EPS (Basic) | $2.74 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.14B | -16.6% |
| Accounts Receivable | $893.4M | +17.1% |
| Current Assets | $3.48B | +4.4% |
| Total Assets | $5.34B | +48.6% |
| Current Liabilities | $398.1M | +25.6% |
| Total Liabilities | $591.5M | +17.4% |
| Stockholders' Equity | $4.75B | +53.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $964.6M | +57.4% |
| Capital Expenditures | $24.6M | +205.2% |
| Investing Cash Flow | -$221.0M | -497.5% |
| Financing Cash Flow | -$968.3M | -17.1% |
| Free Cash Flow | $940.0M | +55.4% |
| +5580.0% |
| EPS (Diluted) | $2.67 | +5440.0% |